$1.87 Billion is the total value of Artal Group S.A.'s 137 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 13.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARGX | Sell | ARGENX SEsponsored adr | $151,552,000 | -18.2% | 400,000 | -31.9% | 8.10% | +4.4% |
| LXRX | LEXICON PHARMACEUTICALS INC | $132,392,000 | -11.0% | 71,178,364 | 0.0% | 7.07% | +13.5% | |
| BGNE | Sell | BEIGENE LTDsponsored adr | $105,203,000 | -16.1% | 650,000 | -2.3% | 5.62% | +7.0% |
| WW | WW INTL INC | $94,689,000 | -37.5% | 14,818,300 | 0.0% | 5.06% | -20.3% | |
| SGEN | Sell | SEAGEN INC | $92,894,000 | -0.8% | 525,000 | -19.2% | 4.96% | +26.6% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $87,510,000 | -17.6% | 600,000 | -7.7% | 4.67% | +5.2% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $73,843,000 | -33.5% | 1,100,000 | -18.5% | 3.94% | -15.1% |
| BLU | Sell | BELLUS HEALTH INC NEW | $64,680,000 | +10.6% | 7,000,000 | -17.6% | 3.46% | +41.1% |
| FATE | Buy | FATE THERAPEUTICS INC | $64,428,000 | -16.9% | 2,600,000 | +30.0% | 3.44% | +6.0% |
| CYTK | Buy | CYTOKINETICS INC | $50,095,000 | +36.1% | 1,275,000 | +27.5% | 2.68% | +73.7% |
| SRRK | Buy | SCHOLAR ROCK HLDG CORP | $48,038,000 | +52.1% | 8,750,034 | +257.1% | 2.57% | +94.1% |
| C | New | CITIGROUP INCcall | $45,990,000 | – | 1,000,000 | +100.0% | 2.46% | – |
| FOLD | AMICUS THERAPEUTICS INC | $42,960,000 | +13.4% | 4,000,000 | 0.0% | 2.30% | +44.7% | |
| SEER | SEER INC | $42,513,000 | -41.3% | 4,750,000 | 0.0% | 2.27% | -25.1% | |
| CERE | CEREVEL THERAPEUTICS HLDNG I | $39,660,000 | -24.5% | 1,500,000 | 0.0% | 2.12% | -3.7% | |
| IGMS | IGM BIOSCIENCES INC | $36,060,000 | -32.5% | 2,000,000 | 0.0% | 1.93% | -13.9% | |
| MORF | MORPHIC HLDG INC | $35,805,000 | -46.0% | 1,650,000 | 0.0% | 1.91% | -31.1% | |
| KRYS | KRYSTAL BIOTECH INC | $32,830,000 | -1.3% | 500,000 | 0.0% | 1.75% | +25.8% | |
| LABU | New | DIREXION SHS ETF TRcall | $26,960,000 | – | 4,000,000 | +100.0% | 1.44% | – |
| FHTX | FOGHORN THERAPEUTICS INC | $23,402,000 | -10.7% | 1,720,720 | 0.0% | 1.25% | +13.9% | |
| SWTX | Buy | SPRINGWORKS THERAPEUTICS INC | $22,158,000 | -53.8% | 900,000 | +5.9% | 1.18% | -41.1% |
| GOSS | GOSSAMER BIO INC | $19,745,000 | -3.6% | 2,358,968 | 0.0% | 1.06% | +23.1% | |
| KYMR | KYMERA THERAPEUTICS INC | $19,690,000 | -53.5% | 1,000,000 | 0.0% | 1.05% | -40.6% | |
| KURA | KURA ONCOLOGY INC | $19,247,000 | +14.0% | 1,050,000 | 0.0% | 1.03% | +45.4% | |
| EQRX INC | $18,760,000 | +13.6% | 4,000,000 | 0.0% | 1.00% | +44.8% | ||
| SDGR | SCHRODINGER INC | $18,487,000 | -22.6% | 700,000 | 0.0% | 0.99% | -1.3% | |
| GBIO | GENERATION BIO CO | $18,461,000 | -10.6% | 2,814,191 | 0.0% | 0.99% | +14.0% | |
| ERASCA INC | $17,669,000 | -35.2% | 3,172,221 | 0.0% | 0.94% | -17.3% | ||
| DNLI | DENALI THERAPEUTICS INC | $17,658,000 | -8.5% | 600,000 | 0.0% | 0.94% | +16.7% | |
| REPL | REPLIMUNE GROUP INC | $15,732,000 | +2.9% | 900,000 | 0.0% | 0.84% | +31.2% | |
| SAGE | Sell | SAGE THERAPEUTICS INC | $14,535,000 | -41.5% | 450,000 | -40.0% | 0.78% | -25.3% |
| NTLA | INTELLIA THERAPEUTICS INC | $14,234,000 | -28.8% | 275,000 | 0.0% | 0.76% | -9.2% | |
| EVTCY | EVOTEC AGsponsored ads | $13,770,000 | -20.8% | 1,149,425 | 0.0% | 0.74% | +1.0% | |
| RLAY | RELAY THERAPEUTICS INC | $11,725,000 | -44.0% | 700,000 | 0.0% | 0.63% | -28.6% | |
| MRSN | MERSANA THERAPEUTICS INC | $10,164,000 | +15.8% | 2,200,000 | 0.0% | 0.54% | +47.6% | |
| AUPH | AURINIA PHARMACEUTICALS INC | $10,050,000 | -18.8% | 1,000,000 | 0.0% | 0.54% | +3.7% | |
| RPTX | REPARE THERAPEUTICS INC | $9,793,000 | -1.8% | 700,000 | 0.0% | 0.52% | +25.4% | |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $9,750,000 | +387.5% | 3,000,000 | +200.0% | 0.52% | +520.2% |
| IMAB | I MABsponsored ads | $9,605,000 | -30.4% | 850,000 | 0.0% | 0.51% | -11.2% | |
| TALS | TALARIS THERAPEUTICS INC | $9,310,000 | -54.2% | 2,064,262 | 0.0% | 0.50% | -41.5% | |
| ALVR | ALLOVIR INC | $9,061,000 | -42.2% | 2,323,371 | 0.0% | 0.48% | -26.3% | |
| OMEGA THERAPEUTICS INC | $8,639,000 | -39.1% | 2,273,530 | 0.0% | 0.46% | -22.4% | ||
| ITOS | ITEOS THERAPEUTICS INC | $8,240,000 | -36.0% | 400,000 | 0.0% | 0.44% | -18.4% | |
| ATRA | ATARA BIOTHERAPEUTICS INC | $7,790,000 | -16.1% | 1,000,000 | 0.0% | 0.42% | +6.9% | |
| OMEG | OMEGA ALPHA SPACcl a | $7,388,000 | +0.3% | 750,000 | 0.0% | 0.40% | +28.2% | |
| IKNA | IKENA ONCOLOGY INC | $6,864,000 | -27.4% | 1,549,513 | 0.0% | 0.37% | -7.3% | |
| SELB | Buy | SELECTA BIOSCIENCES INC | $6,397,000 | +30.0% | 4,883,200 | +22.1% | 0.34% | +66.0% |
| VERV | VERVE THERAPEUTICS INC | $6,112,000 | -33.0% | 400,000 | 0.0% | 0.33% | -14.7% | |
| YMAB | Y-MABS THERAPEUTICS INC | $6,052,000 | +27.4% | 400,000 | 0.0% | 0.32% | +62.3% | |
| EXSCIENTIA PLCads | $5,990,000 | -24.4% | 550,000 | 0.0% | 0.32% | -3.6% | ||
| AGEN | Sell | AGENUS INC | $5,820,000 | -57.0% | 3,000,000 | -45.5% | 0.31% | -45.1% |
| AMAM | AMBRX BIOPHARMA INCsponsored ads | $5,704,000 | -35.7% | 2,152,291 | 0.0% | 0.30% | -17.8% | |
| ACHL | ACHILLES THERAPEUTICS PLCsponsored ads | $5,684,000 | -14.3% | 2,255,375 | 0.0% | 0.30% | +9.4% | |
| KRON | KRONOS BIO INC | $5,616,000 | -49.7% | 1,542,954 | 0.0% | 0.30% | -35.8% | |
| DSGN | DESIGN THERAPEUTICS INC | $5,600,000 | -13.3% | 400,000 | 0.0% | 0.30% | +10.7% | |
| OVID | OVID THERAPEUTICS INC | $5,375,000 | -31.5% | 2,500,000 | 0.0% | 0.29% | -12.8% | |
| OTLY | OATLY GROUP ABsponsored ads | $5,190,000 | -30.9% | 1,500,000 | 0.0% | 0.28% | -12.1% | |
| SQZ | SQZ BIOTECHNOLOGIES CO | $5,108,000 | -33.9% | 1,606,309 | 0.0% | 0.27% | -15.5% | |
| ALPN | ALPINE IMMUNE SCIENCES INC | $5,047,000 | -5.1% | 593,030 | 0.0% | 0.27% | +21.1% | |
| MARINUS PHARMACEUTICALS INC | $4,840,000 | -48.2% | 1,000,000 | 0.0% | 0.26% | -33.8% | ||
| LPTX | LEAP THERAPEUTICS INC | $4,600,000 | -34.3% | 4,000,000 | 0.0% | 0.25% | -16.0% | |
| CFRX | CONTRAFECT CORP | $4,605,000 | -15.9% | 1,500,000 | 0.0% | 0.25% | +7.4% | |
| LYEL | LYELL IMMUNOPHARMA INC | $4,564,000 | +29.1% | 700,000 | 0.0% | 0.24% | +64.9% | |
| ALXO | ALX ONCOLOGY HLDGS INC | $4,045,000 | -52.1% | 500,000 | 0.0% | 0.22% | -39.0% | |
| BDTX | BLACK DIAMOND THERAPEUTICS I | $4,050,000 | -11.2% | 1,646,517 | 0.0% | 0.22% | +13.1% | |
| TSHA | TAYSHA GENE THERAPIES INC | $3,872,000 | -42.9% | 1,040,882 | 0.0% | 0.21% | -27.1% | |
| SYRS | Buy | SYROS PHARMACEUTICALS INC | $3,851,000 | -7.5% | 4,000,000 | +14.3% | 0.21% | +18.4% |
| SE | SEA LTDsponsored ads | $3,844,000 | -44.2% | 57,500 | 0.0% | 0.20% | -28.8% | |
| NBTX | NANOBIOTIXsponsored ads | $3,800,000 | -48.9% | 1,000,000 | 0.0% | 0.20% | -34.7% | |
| PORTAGE FINTECH ACQUISITN CO | $3,705,000 | -1.8% | 380,000 | 0.0% | 0.20% | +25.3% | ||
| RXRX | RECURSION PHARMACEUTICALS INcl a | $3,663,000 | +13.7% | 450,000 | 0.0% | 0.20% | +45.2% | |
| RNA | AVIDITY BIOSCIENCES INC | $3,633,000 | -21.3% | 250,000 | 0.0% | 0.19% | +0.5% | |
| ACIU | AC IMMUNE SA | $3,610,000 | -9.8% | 1,000,000 | 0.0% | 0.19% | +15.6% | |
| DYN | DYNE THERAPEUTICS INC | $3,607,000 | -28.7% | 525,000 | 0.0% | 0.19% | -9.0% | |
| ADVM | ADVERUM BIOTECHNOLOGIES INC | $3,600,000 | -8.4% | 3,000,000 | 0.0% | 0.19% | +16.4% | |
| APTX | APTINYX INC | $3,412,000 | -75.4% | 6,116,493 | 0.0% | 0.18% | -68.7% | |
| STOK | STOKE THERAPEUTICS INC | $3,303,000 | -37.2% | 250,000 | 0.0% | 0.18% | -20.0% | |
| ADAGIO THERAPEUTICS INC | $3,280,000 | -28.1% | 1,000,000 | 0.0% | 0.18% | -8.4% | ||
| CGEM | CULLINAN ONCOLOGY INC | $3,205,000 | +22.4% | 250,000 | 0.0% | 0.17% | +55.5% | |
| RUBY | RUBIUS THERAPEUTICS INC | $3,149,000 | -84.6% | 3,701,580 | 0.0% | 0.17% | -80.3% | |
| HOOK | HOOKIPA PHARMA INC | $3,015,000 | -28.5% | 1,849,616 | 0.0% | 0.16% | -9.0% | |
| PRAX | PRAXIS PRECISION MEDICINES I | $2,940,000 | -76.0% | 1,200,000 | 0.0% | 0.16% | -69.4% | |
| VIGIL NEUROSCIENCE INC | $2,893,000 | -63.3% | 1,121,191 | 0.0% | 0.16% | -53.0% | ||
| MIRION TECHNOLOGIES INC | $2,880,000 | -28.6% | 500,000 | 0.0% | 0.15% | -8.9% | ||
| VOR | VOR BIOPHARMA INC | $2,734,000 | -17.7% | 550,000 | 0.0% | 0.15% | +5.0% | |
| New | CINCOR PHARMA INC | $2,581,000 | – | 137,010 | +100.0% | 0.14% | – | |
| SANA | SANA BIOTECHNOLOGY INC | $2,572,000 | -22.2% | 400,000 | 0.0% | 0.14% | -0.7% | |
| IMUX | IMMUNIC INC | $2,429,000 | -69.3% | 700,000 | 0.0% | 0.13% | -60.7% | |
| ZYME | ZYMEWORKS INC | $2,385,000 | -19.1% | 450,000 | 0.0% | 0.13% | +3.3% | |
| BBIO | BRIDGEBIO PHARMA INC | $2,270,000 | -10.6% | 250,000 | 0.0% | 0.12% | +14.2% | |
| TCRR | TCR2 THERAPEUTICS INC | $2,175,000 | +5.1% | 750,000 | 0.0% | 0.12% | +33.3% | |
| TIL | INSTIL BIO INC | $2,079,000 | -57.0% | 450,000 | 0.0% | 0.11% | -45.3% | |
| New | SENTI BIOSCIENCES INC | $2,074,000 | – | 1,055,555 | +100.0% | 0.11% | – | |
| ADAG | ADAGENE INCads | $2,066,000 | -41.0% | 1,000,000 | 0.0% | 0.11% | -25.2% | |
| IMMP | IMMUTEP LTDsponsored ads | $2,030,000 | -25.9% | 1,000,000 | 0.0% | 0.11% | -6.1% | |
| YI | 111 INCads | $1,991,000 | -22.5% | 966,349 | 0.0% | 0.11% | -1.9% | |
| GRPH | GRAPHITE BIO INC | $1,925,000 | -46.1% | 700,000 | 0.0% | 0.10% | -30.9% | |
| NEXI | NEXIMMUNE INC | $1,932,000 | -61.8% | 1,200,000 | 0.0% | 0.10% | -51.4% | |
| HARP | HARPOON THERAPEUTICS INC | $1,910,000 | -61.6% | 1,000,000 | 0.0% | 0.10% | -51.0% | |
| FUSN | FUSION PHARMACEUTICALS INC | $1,868,000 | -67.9% | 750,000 | 0.0% | 0.10% | -59.0% | |
| SLDB | SOLID BIOSCIENCES INC | $1,847,000 | -48.7% | 3,000,000 | 0.0% | 0.10% | -34.4% | |
| GRTS | GRITSTONE BIO INC | $1,815,000 | -41.3% | 750,000 | 0.0% | 0.10% | -24.8% | |
| ORIC | ORIC PHARMACEUTICALS INC | $1,792,000 | -16.1% | 400,000 | 0.0% | 0.10% | +7.9% | |
| MREO | MEREO BIOPHARMA GROUP PLCads | $1,680,000 | 0.0% | 1,500,000 | 0.0% | 0.09% | +28.6% | |
| CRDF | CARDIFF ONCOLOGY INC | $1,650,000 | -11.3% | 750,000 | 0.0% | 0.09% | +12.8% | |
| ME | 23ANDME HOLDING CO | $1,639,000 | -35.3% | 661,009 | 0.0% | 0.09% | -17.0% | |
| KNTE | KINNATE BIOPHARMA INC | $1,576,000 | +11.9% | 125,000 | 0.0% | 0.08% | +42.4% | |
| CYCN | CYCLERION THERAPEUTICS INC | $1,525,000 | -50.6% | 2,779,122 | 0.0% | 0.08% | -37.2% | |
| AMYLYX PHARMACEUTICALS INC | $1,445,000 | +49.9% | 75,000 | 0.0% | 0.08% | +92.5% | ||
| AXLA | AXCELLA HEALTH INC | $1,446,000 | -21.0% | 712,500 | 0.0% | 0.08% | 0.0% | |
| XILIO THERAPEUTICS INC | $1,314,000 | -58.7% | 450,000 | 0.0% | 0.07% | -47.4% | ||
| ARAV | ARAVIVE INC | $1,295,000 | -48.8% | 1,311,291 | 0.0% | 0.07% | -34.9% | |
| CRIS | CURIS INC | $1,280,000 | -58.6% | 1,300,000 | 0.0% | 0.07% | -47.7% | |
| IRWD | IRONWOOD PHARMACEUTICALS INC | $1,274,000 | -8.3% | 110,532 | 0.0% | 0.07% | +17.2% | |
| OLMA | OLEMA PHARMACEUTICALS INC | $1,060,000 | -4.5% | 260,500 | 0.0% | 0.06% | +23.9% | |
| ORTX | ORCHARD THERAPEUTICS PLCads | $1,054,000 | -17.9% | 1,803,858 | 0.0% | 0.06% | +3.7% | |
| IGMS | New | IGM BIOSCIENCES INCcall | $902,000 | – | 50,000 | +100.0% | 0.05% | – |
| LVTX | LAVA THERAPEUTICS NV | $590,000 | -33.0% | 200,000 | 0.0% | 0.03% | -13.5% | |
| MEIP | MEI PHARMA INC | $605,000 | +0.3% | 1,000,000 | 0.0% | 0.03% | +28.0% | |
| CDAK | CODIAK BIOSCIENCES INC | $576,000 | -54.1% | 200,000 | 0.0% | 0.03% | -41.5% | |
| CARIBOU BIOSCIENCES INC | $572,000 | -40.8% | 105,347 | 0.0% | 0.03% | -22.5% | ||
| HIPPO HLDGS INC | $527,000 | -55.9% | 600,000 | 0.0% | 0.03% | -44.0% | ||
| CRVS | CORVUS PHARMACEUTICALS INC | $495,000 | -39.6% | 500,000 | 0.0% | 0.03% | -23.5% | |
| MTCR | METACRINE INC | $462,000 | -18.1% | 924,898 | 0.0% | 0.02% | +4.2% | |
| MINK THERAPEUTICS INC | $408,000 | -37.4% | 289,588 | 0.0% | 0.02% | -18.5% | ||
| YMTX | YUMANITY THERAPEUTICS INC | $396,000 | +21.5% | 217,391 | 0.0% | 0.02% | +50.0% | |
| CLF | New | CLEVELAND-CLIFFS INC NEW | $384,000 | – | 25,000 | +100.0% | 0.02% | – |
| SPRO | SPERO THERAPEUTICS INC | $371,000 | -91.5% | 500,000 | 0.0% | 0.02% | -89.0% | |
| APLT | APPLIED THERAPEUTICS INC | $379,000 | -55.1% | 400,000 | 0.0% | 0.02% | -42.9% | |
| UNG | New | UNITED STS NAT GAS FD LPunit par | $380,000 | – | 20,000 | +100.0% | 0.02% | – |
| New | BATH & BODY WORKS INC | $337,000 | – | 12,500 | +100.0% | 0.02% | – | |
| SGTX | SIGILON THERAPEUTICS INC | $229,000 | -43.6% | 276,000 | 0.0% | 0.01% | -29.4% | |
| CDTX | CIDARA THERAPEUTICS INC | $110,000 | -41.2% | 224,675 | 0.0% | 0.01% | -25.0% | |
| ASTRIA THERAPEUTICS INC | $100,000 | -55.4% | 33,333 | 0.0% | 0.01% | -44.4% | ||
| KLDO | KALEIDO BIOSCIENCES INC | $31,000 | -96.2% | 500,500 | 0.0% | 0.00% | -94.3% | |
| Exit | GINKGO BIOWORKS HOLDINGS INC | $0 | – | -50,000 | -100.0% | -0.01% | – | |
| XP | Exit | XP INCcl a | $0 | – | -35,000 | -100.0% | -0.04% | – |
| DYNS | Exit | DYNAMICS SPECIAL PURPOSE COR | $0 | – | -500,000 | -100.0% | -0.21% | – |
| IMCR | Exit | IMMUNOCORE HLDGS PLCads | $0 | – | -200,000 | -100.0% | -0.25% | – |
| TGTX | Exit | TG THERAPEUTICS INC | $0 | – | -800,000 | -100.0% | -0.32% | – |
| SAGE | Exit | SAGE THERAPEUTICS INCcall | $0 | – | -250,000 | -100.0% | -0.35% | – |
| FMTX | Exit | FORMA THERAPEUTICS HLDGS INC | $0 | – | -1,000,000 | -100.0% | -0.39% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -200,000 | -100.0% | -0.42% | – |
| INTC | Exit | INTEL CORPcall | $0 | – | -300,000 | -100.0% | -0.62% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -800,100 | -100.0% | -0.79% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AGENUS INC | 42 | Q3 2023 | 1.9% |
| IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
| ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
| LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
| AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
| BEIGENE LTD | 28 | Q3 2023 | 7.4% |
| BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
| SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
| AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
| NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-25 |
| 4 | 2024-03-13 |
| 4 | 2024-02-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-16 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-06-22 |
| 3 | 2023-06-15 |
| 4 | 2023-06-05 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.